Stay updated on Switching to Cabotegravir and Rilpivirine: Clinical Trial

Sign up to get notified when there's something new on the Switching to Cabotegravir and Rilpivirine: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Switching to Cabotegravir and Rilpivirine: Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.2, replacing the previous Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T10:44:21.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0; Deleted Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T17:58:28.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 from the page.
    Difference
    0.0%
    Check dated 2026-03-11T15:27:33.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the page; the content appears unchanged.
    Difference
    0.0%
    Check dated 2026-02-25T07:25:01.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and a funding-status notice along with Revision: v3.4.1 were removed. These changes are cosmetic and do not affect study details or user actions on the page.
    Difference
    0.2%
    Check dated 2026-02-11T02:05:30.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    A Notice about a lapse in government funding and NIH Clinical Center status was added, with links to cc.nih.gov and opm.gov for updates. The site revision tag was updated from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-04T00:29:04.000Z thumbnail image

Stay in the know with updates to Switching to Cabotegravir and Rilpivirine: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Switching to Cabotegravir and Rilpivirine: Clinical Trial page.